Your SlideShare is downloading. ×
Paraneoplastic  syndromes
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Paraneoplastic syndromes


Published on

Published in: Health & Medicine

1 Comment
No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. PARANEOPLASTIC SYNDROMES Presentation BY DR Mohammad Shafi Moona
  • 2.  Paraneoplastic Syndromes: Paraneoplastic syndromes are a group of disorders associated with specific neoplsms that have signs and symptoms at sites distant from the primary tumor or its metastasis. The syndrome may be due to: Production of substances that directly or indirectly cause distant symptoms.
  • 3.  PS ARE DIVIDED IN TO 1) Endocrine PS. 2) Neurological PS. 3) Haematological PS.
  • 4.  1): Syndrome of inappropriate ADH( SIADH): Hyponaremia is the primary biochemical indicator of clinically inappropriate secretion of ADH. CAUSES : SCLC 15 %. Pancreatic Ca. Carcinoid tumors. Head & neck cancer. Chemotherapy induced transient hyponatremia
  • 5.  Presentation: Asymptomatic. Fatigue, anorexia, headache and mild altered mental status. Delirium , confusion & seizures.
  • 6.  Laboratory criteria for diagnosis: Hypnatremia Na<130 mEq/L. Normal serum albumin & glucose. Serum hypo osmolality <280 mOsm/kg. Urine osmolality >100 mOsm/Kg. Urinary sodium > 20 mEq/L. Non suppressed ADH.
  • 7.  Differential diagnosis: C.H.F. Nephrotic syndrome. Malignant ascites. Liver diseases.
  • 8.  Treatment: Fluid restriction to less than 1 litre/day if Na>125. Demeclocycline. Infusion of 3% saline at a rate of 0.1 ml/Kg/min for 24 hours. Frusemide. For long term treatment : Demeclocycline ( 1gm/day for 2 weeks). Fludrocortisone ( 0.1- 0.3mg twice daily). Lithium carbonate.
  • 9.  2) Cushings syndrome : Production of ACTH or ACTH like substances which lead to adrenal hyperplasia & hypercortisolism. CAUSES : SCLC, NSCLC, pancreatic, thymic and carcinoid tumors medullary carcinoma of thyroid, pheochromocytoma. Presentation : Muscle wasting . Weakness secondary to proximal myopathy. Hyperpigmentaton, hypertension, glucose intolerance. Abnormal fat distribution, hypokalaemic alkalosis.
  • 10.  Diagnosis : In primary adrenal hyperplasia ACTH plasma level will be low. In ACTH dependent cushing syndrome (ACTH high) In ectopic ACTH production (plasma ACTH & ACTH precursor levels are very high) 24 hour urinary cortisol. Low dose dexamethasone suppression test. High dose dexamethasone suppression test. Hpokalaemia & metabolic alkalosis . High plasma ACTH with no response to high dose dexamethasone suppression test.
  • 11.  TREATMENT: Surgery. Bilateral adrenalectomy ( occult ACTH production, severe muscle weakness, & uncontrolled hypertension). Use of octreotide, ketoconazole & metyrapone.
  • 12.  3): Hypercalcemia: Due to tumour production of parathyroid hormone related protein. CAUSES: Highest : multiple myeloma , Ca breast. Lowest : NSCLC ,colon prostate & SCLC.
  • 13.  Presentation: Nausea, polyuria, polydipsia, dehydration & cardiac arrhythmias. Differential diagnosis: Primary hyperparathyroidism (adenoma or hyperlasia of parathyroid glands)
  • 14.  Malignancy: a) Osteolytic hypercalcemia: Due to producton of interleukin 1( ca breast, NSCLC, myeloma & lymphoma). b) Humoral hypercalcemia of malignancy: secretion of PTH-related protein which act via PTH receptors (SCC of lung, head & neck cancer, ca bladder & ovarian carcinoma).
  • 15.  DIAGNOSIS : Serum ca>10.3 mg/dl or ionized ca>5.2 mg/dl. Serum chloride low. Hypercalciuria. High urinary phosphate. Low/undetectable plasma parathyroid hormone. TREATMENT: Saline hydration, biphosphonates.
  • 16.  4) Hypoglycemia: Non-insulinoma associated hypoglycemia or non-islet cell tumor hypoglycemia. Occuring in patients with tumors of mesenchymal origin(retroperitoneal, intrathoracic & intraperitoneal) & hepatoma. Secretion of insulin like growth factor . Plasma insulin level low. Management: Palliative or surgical .
  • 17.  5) Cerebellar degeneration: Seen in < 1% of patients. Causes: Ca breast , Small cell lung cancer , Ca ovary, endometrial & fallopian tube cancers . Pathogenesis: Anti Yo antibody directed agaanist purkinje cells & tumor cells with there shared antigen. Presentation: Visual loss, vertigo & truncal ataxia. Diagnosis: Immunofluorescent method.
  • 18.  Management: Steroid . I/V immunoglobulin. Plasmapheresis. Chemotherapy.
  • 19.  6) Lambert-Eaton myasthenic syndrome: Cause: Small cell lung cancer. Pathogenesis: Autoantibody that reacts with voltage-gated calcium channels of peripheral cholinergic nerve terminals and tumor cell membranes. Presentation: Proximal muscle weakness (pelvic girdle) Hyporeflexia, muscle tenderness . Autonomic dysfunction ( orthostatic hypotension, dry mouth). 30% of patients have dysphagia.
  • 20.  Diagnosis : EMG findings (muscle action potential that increase after brief exercise. Management:. Azathiopirine. Immunoglobulin. Plasma exchange
  • 21.  7)Erythrocytosis: 1) High erythropoietin production: RCC , Hepatoma, Cerebellar haemangioblastoma. Uterine fibroids , Adrenal tumors Phaechromocytoma . 2) Adrenal cortical tumors : Production of androgen hormones 3)Prosrtoglandin production by tumors: Treatment: Phlebotomy: Hematocrit > 55% in males > 50 in females.
  • 22.  8) Granulocytosis: WBC > 15000 Causes : Hodgkins disease. Solid tumors ( gastric, lung, pancreatic, brain & malignant melanoma). Mechanism: Production of growth factors including GCSF & GMCSF.
  • 23.